Results 141 to 150 of about 5,631 (161)
We evaluated switching from brinzolamide 1% or brimonidine 0.1% to a fixed-combination of brinzolamide 1% and brimonidine 0.1%, and then determined the efficacy, safety, and satisfaction associated with these changes in glaucoma patients.
Yoshiaki Kiuchi +2 more
exaly +2 more sources
Objectives: The purpose of this study was to investigate switching from brimonidine and ripasudil, and brimonidine or ripasudil, to a fixed combination of brimonidine and ripasudil, and evaluate the associated efficacy and safety in glaucoma patients ...
Yoshiaki Kiuchi +2 more
exaly +2 more sources
Brimonidine (Alphagan®): A Clinical Profile Four Years after Launch
The early information on the clinical efficacy, safety, and tolerability of brimonidine 0.2% were obtained from studies that compared brimonidine monotherapy with timolol and betaxolol. These studies showed its intra-ocular pressure lowering efficacy to
R. David
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Difference in vasoconstrictors: oxymetazoline vs. brimonidine
Journal of Dermatological Treatment, 2021Steven R. Feldman, Abigail Cline
exaly
Adverse effects of brimonidine eye drop in children: A case series
Journal of Clinical Pharmacy and Therapeutics, 2021Zahra Ghaffari +2 more
exaly
Efficacy, safety, and current applications of brimonidine
Expert Opinion on Drug Safety, 2008L Jay Katz
exaly
Comparison of brimonidine with latanoprost in the adjunctive treatment of glaucoma
Clinical Therapeutics, 2000Steven T Simmons
exaly

